Tissue specific LRRK2 interactomes reveal a distinct striatal functional unit
暂无分享,去创建一个
[1] E. Tolosa,et al. LRRK2 in Parkinson disease: challenges of clinical trials , 2020, Nature Reviews Neurology.
[2] Eun-Jin Bae,et al. The LRRK2-RAB axis in regulation of vesicle trafficking and α-synuclein propagation. , 2019, Biochimica et biophysica acta. Molecular basis of disease.
[3] D. Berwick,et al. LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same , 2019, Molecular Neurodegeneration.
[4] A. Lees,et al. Lower nucleus accumbens α-synuclein load and D3 receptor levels in Parkinson's disease with impulsive compulsive behaviours. , 2019, Brain : a journal of neurology.
[5] Liam J. McGuffin,et al. PINOT: an intuitive resource for integrating protein-protein interactions , 2019, Cell Communication and Signaling.
[6] S. Pizzi,et al. Kinase inhibition of G2019S-LRRK2 enhances autolysosome formation and function to reduce endogenous alpha-synuclein intracellular inclusions , 2019, Cell Death Discovery.
[7] K. Patrick,et al. LRRK2 regulates innate immune responses and neuroinflammation during Mycobacterium tuberculosis infection , 2019, bioRxiv.
[8] J. Vilo,et al. g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update) , 2019, Nucleic Acids Res..
[9] W. Seol,et al. Rab GTPases as Physiological Substrates of LRRK2 Kinase , 2019, Experimental neurobiology.
[10] G. Fink,et al. Dopamine metabolism of the nucleus accumbens and fronto-striatal connectivity modulate impulse control , 2019, Brain : a journal of neurology.
[11] L. Civiero,et al. The role of LRRK2 in cytoskeletal dynamics. , 2018, Biochemical Society transactions.
[12] T. Iwatsubo,et al. LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis , 2018, Proceedings of the National Academy of Sciences.
[13] Ajay S. Kurani,et al. Altered resting‐state functional connectivity of the putamen and internal globus pallidus is related to speech impairment in Parkinson's disease , 2018, Brain and behavior.
[14] Tao Wu,et al. Consistent decreased activity in the putamen in Parkinson's disease: a meta-analysis and an independent validation of resting-state fMRI , 2018, GigaScience.
[15] T. Dawson,et al. Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration , 2018, Molecular Neurodegeneration.
[16] Judy H. Cho,et al. Functional variants in the LRRK2 gene confer shared effects on risk for Crohn’s disease and Parkinson’s disease , 2018, Science Translational Medicine.
[17] T. Iwatsubo,et al. Parkinson's disease-associated mutant LRRK2 phosphorylates Rab7L1 and modifies trans-Golgi morphology. , 2018, Biochemical and biophysical research communications.
[18] S. Pfeffer,et al. Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase , 2017, The EMBO journal.
[19] Yanhui Hu,et al. Molecular Interaction Search Tool (MIST): an integrated resource for mining gene and protein interaction data , 2017, Nucleic Acids Res..
[20] T. Gasser,et al. Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils , 2017, The Biochemical journal.
[21] S. Factor,et al. LRRK2 levels in immune cells are increased in Parkinson’s disease , 2017, npj Parkinson's Disease.
[22] Martin H. Schaefer,et al. HIPPIE v2.0: enhancing meaningfulness and reliability of protein–protein interaction networks , 2016, Nucleic Acids Res..
[23] M. Cookson,et al. mTOR independent regulation of macroautophagy by Leucine Rich Repeat Kinase 2 via Beclin-1 , 2016, Scientific Reports.
[24] M. Ueffing,et al. Structural model of the dimeric Parkinson’s protein LRRK2 reveals a compact architecture involving distant interdomain contacts , 2016, Proceedings of the National Academy of Sciences.
[25] L. Abel,et al. A Missense LRRK2 Variant Is a Risk Factor for Excessive Inflammatory Responses in Leprosy , 2016, PLoS neglected tropical diseases.
[26] Henning Hermjakob,et al. A visual review of the interactome of LRRK2: Using deep-curated molecular interaction data to represent biology , 2015, Proteomics.
[27] Claudia Manzoni,et al. Computational analysis of the LRRK2 interactome , 2015, PeerJ.
[28] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[29] D. Standaert,et al. Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents , 2014, The Journal of comparative neurology.
[30] P. Giunti,et al. Inhibition of LRRK2 kinase activity stimulates macroautophagy , 2013, Biochimica et biophysica acta.
[31] M. Rietschel,et al. Comparison of gene expression profiles in the blood, hippocampus and prefrontal cortex of rats , 2013, In Silico Pharmacology.
[32] R. DePaolo,et al. Genetic variants associated with Crohn’s disease , 2013, The application of clinical genetics.
[33] K. Marder,et al. RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson’s Disease Risk , 2013, Neuron.
[34] C. Manzoni,et al. LRRK2 and Human Disease: A Complicated Question or a Question of Complexes? , 2012, Science Signaling.
[35] Yusuke Nakamura,et al. Meta‐analysis of published studies identified eight additional common susceptibility loci for Crohn's disease and ulcerative colitis , 2011, Inflammatory bowel diseases.
[36] J. Sanders,et al. Leucine-Rich Repeat Kinase 2 (LRRK2) Cellular Biology: A Review of Recent Advances in Identifying Physiological Substrates and Cellular Functions , 2011, Journal of neurogenetics.
[37] C. Wiessner,et al. Regulation of LRRK2 Expression Points to a Functional Role in Human Monocyte Maturation , 2011, PloS one.
[38] M. Kubo,et al. LRRK2 is expressed in B-2 but not in B-1 B cells, and downregulated by cellular activation , 2010, Journal of Neuroimmunology.
[39] Tariq Ahmad,et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci , 2010, Nature Genetics.
[40] M. S. Luciano,et al. LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[41] M. Nalls,et al. Genetic variability at the PARK16 locus , 2010, European Journal of Human Genetics.
[42] Guoping Fan,et al. Signed weighted gene co-expression network analysis of transcriptional regulation in murine embryonic stem cells , 2009, BMC Genomics.
[43] Thomas Schlitt,et al. Protein-protein interaction databases: keeping up with growing interactomes , 2009, Human Genomics.
[44] Judy H. Cho,et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease , 2008, Nature Genetics.
[45] E. Tolosa,et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study , 2008, The Lancet Neurology.
[46] A. Singleton,et al. Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls , 2008, Human mutation.
[47] V. Baekelandt,et al. Distribution of PINK1 and LRRK2 in rat and mouse brain , 2006, Journal of neurochemistry.
[48] Alessandro Vespignani,et al. Global protein function prediction from protein-protein interaction networks , 2003, Nature Biotechnology.
[49] Mourad Sahbatou,et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.
[50] Richard S. J. Frackowiak,et al. Impaired mesial frontal and putamen activation in Parkinson's disease: A positron emission tomography study , 1992, Annals of neurology.
[51] A. Mirelman,et al. Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis. , 2015, JAMA neurology.
[52] G. Halliday,et al. Measurement of LRRK2 and Ser910/935 phosphorylated LRRK2 in peripheral blood mononuclear cells from idiopathic Parkinson's disease patients. , 2013, Journal of Parkinson's disease.
[53] S. Factor,et al. LRRK2 levels in immune cells are increased in Parkinson’s disease , 2017, npj Parkinson's Disease.